These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16891938)

  • 1. The effect of levodopa or levodopa-carbidopa (sinemet) on fracture healing.
    Costa ER; Weinhold P; Tayrose GA; Hooker JA; Dahners LE
    J Orthop Trauma; 2006 Jul; 20(7):470-5. PubMed ID: 16891938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
    Libman I; Gawel MJ; Riopelle RJ; Bouchard S
    Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease.
    Verhagen Metman L; Stover N; Chen C; Cowles VE; Sweeney M
    Mov Disord; 2015 Aug; 30(9):1222-8. PubMed ID: 25847690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
    Brannan T; Yahr MD
    Ann Neurol; 1995 Jan; 37(1):95-8. PubMed ID: 7818264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison between results achieved by administering L-dopa and Sinemet in parkinsonism in the light of our records].
    Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewics E; Wolczyk-Orzechowska M
    Neurol Neurochir Pol; 1975; 9(5):611-5. PubMed ID: 1186952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials.
    Mooney ME; Schmitz JM; Moeller FG; Grabowski J
    Drug Alcohol Depend; 2007 May; 88(2-3):214-23. PubMed ID: 17134849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
    Hayek J
    Schweiz Med Wochenschr; 1977 Apr; 107(14):474-9. PubMed ID: 847450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1.
    Kabel AM; Omar MS; Alhadhrami A; Alharthi SS; Alrobaian MM
    Physiol Behav; 2018 May; 188():108-118. PubMed ID: 29410018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical strength of fracture callus in osteopenic bone at different phases of healing.
    Wheeler DL; Eschbach EJ; Montfort MJ; Maheshwari P; McLoughlin SW
    J Orthop Trauma; 2000 Feb; 14(2):86-92. PubMed ID: 10716378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between the effects of acetaminophen and celecoxib on bone fracture healing in rats.
    Bergenstock M; Min W; Simon AM; Sabatino C; O'Connor JP
    J Orthop Trauma; 2005; 19(10):717-23. PubMed ID: 16314720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-dopa and carbidopa (sinemet) in the management of parkinsonism.
    Critchley E
    Postgrad Med J; 1975 Sep; 51(599):619-21. PubMed ID: 1105500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
    Stocchi F; Rascol O; Kieburtz K; Poewe W; Jankovic J; Tolosa E; Barone P; Lang AE; Olanow CW
    Ann Neurol; 2010 Jul; 68(1):18-27. PubMed ID: 20582993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open trial of controlled release carbidopa/L-dopa (sinemet CR) for the treatment of mild-to-moderate Parkinson's disease.
    Friedman JH; Lannon MC
    Clin Neuropharmacol; 1989 Jun; 12(3):220-3. PubMed ID: 2743346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography.
    Blunt SB; Jenner P; Marsden CD
    Neuroscience; 1991; 43(1):95-110. PubMed ID: 1681462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability studies of oral dosage forms containing levodopa and carbidopa using column-switching chromatography followed by electrochemical detection.
    Sagar KA; Smyth MR
    Analyst; 2000 Mar; 125(3):439-45. PubMed ID: 10829343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa.
    Blunt SB; Jenner P; Marsden CD
    Exp Brain Res; 1992; 88(2):326-40. PubMed ID: 1577107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
    Blunt S; Jenner P; Marsden CD
    Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.
    Pahwa R; Lyons K; McGuire D; Dubinsky R; Hubble JP; Koller WC
    Neurology; 1996 Apr; 46(4):1059-62. PubMed ID: 8780091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].
    Podiwinsky F; Mentasti M; Riederer P; Birkmayer W
    Wien Klin Wochenschr; 1979 May; 91(10):332-7. PubMed ID: 452602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.